CVE-2023-21566

Visual Studio Elevation of Privilege Vulnerability

Description

Visual Studio Elevation of Privilege Vulnerability

Category

7.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.63%
Vendor Advisory microsoft.com
Affected: Microsoft Microsoft Visual Studio 2022 version 17.2
Affected: Microsoft Microsoft Visual Studio 2017 version 15.9 (includes 15.0 - 15.8)
Affected: Microsoft Microsoft Visual Studio 2022 version 17.4
Affected: Microsoft Microsoft Visual Studio 2022 version 17.0
Affected: Microsoft Microsoft Visual Studio 2019 version 16.11 (includes 16.0 - 16.10)
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2023-21566?
CVE-2023-21566 has been scored as a high severity vulnerability.
How to fix CVE-2023-21566?
To fix CVE-2023-21566, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-21566 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-21566 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-21566?
CVE-2023-21566 affects Microsoft Microsoft Visual Studio 2022 version 17.2, Microsoft Microsoft Visual Studio 2017 version 15.9 (includes 15.0 - 15.8), Microsoft Microsoft Visual Studio 2022 version 17.4, Microsoft Microsoft Visual Studio 2022 version 17.0, Microsoft Microsoft Visual Studio 2019 version 16.11 (includes 16.0 - 16.10).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.